{"id":54842,"date":"2022-02-22T07:32:25","date_gmt":"2022-02-22T06:32:25","guid":{"rendered":"https:\/\/smarthealth.live\/?p=54842"},"modified":"2022-02-22T09:47:40","modified_gmt":"2022-02-22T08:47:40","slug":"bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy","status":"publish","type":"post","link":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/","title":{"rendered":"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy"},"content":{"rendered":"\n

La soci\u00e9t\u00e9 Femtech Bellabeat est sur le point de demander l'approbation de la Food and Drug Administration (FDA) am\u00e9ricaine pour son tracker de sant\u00e9 Ivy. Si l\u2019approbation est positive, le wearable pourra \u00eatre soumis \u00e0 des essais cliniques. Une avanc\u00e9e notable qui permettra aux m\u00e9decins et aux cliniciens de surveiller le cycle menstruel des patientes dans le cadre du traitement de l'infertilit\u00e9, de la d\u00e9pression postnatale et de la m\u00e9nopause.<\/strong><\/p>\n\n\n\n

Bellabeat d\u00e9veloppe divers dispositifs de sant\u00e9 qui ressemblent \u00e0 des bijoux fins. La soci\u00e9t\u00e9 femtech indique qu'avec le bracelet intelligent Ivy, elle surveille en temps r\u00e9el la fr\u00e9quence cardiaque, la temp\u00e9rature corporelle, les calories, les pas, la qualit\u00e9 du sommeil, la respiration, l'hydratation et la coh\u00e9rence cardiaque. Ces donn\u00e9es servent \u00e0 d\u00e9terminer l'\u00e9tat physique et mental de l'utilisatrice. En outre, la marque affirme que Ivy peut enregistrer les menstruations. Un algorithme calcule et pr\u00e9dit, sur la base des donn\u00e9es de sant\u00e9, les prochaines r\u00e8gles et les jours fertiles. Les femmes peuvent \u00e9galement suivre leur grossesse dans l'application.<\/p>\n\n\n\n

Les donn\u00e9es de sant\u00e9 sont visibles par l'utilisatrice dans l'application. Ils relient les donn\u00e9es \u00e0 des scores de pr\u00e9paration et de bien-\u00eatre. Des notations similaires que vous retrouvez \u00e9galement dans d'autres marques de wearables comme Oura<\/a>, Fitbot et Garmin<\/a>. Gr\u00e2ce \u00e0 ces scores, les personnes peuvent, via un Bellabeat premium (abonnement), se mettre au travail avec des recommandations cibl\u00e9es de coachs en mati\u00e8re d'exercices et de r\u00e9gime alimentaire. Ce qui est remarquable, c'est que le site web ne mentionne aucune sp\u00e9cification sur les types de capteurs que la soci\u00e9t\u00e9 utilise pour surveiller et pr\u00e9voir la sant\u00e9 des femmes.<\/p>\n\n\n\n

\"Ivy\"<\/figure>\n\n\n\n

Processus d'approbation de la FDA<\/h3>\n\n\n\n

Il ne sera pas facile pour Bellabeat d'obtenir l'approbation de la FDA pour son tracker de bien-\u00eatre Ivy. La soci\u00e9t\u00e9 franco-am\u00e9ricaine Withings a eu besoin de plusieurs ann\u00e9es pour faire approuver la ScanWatch et le Move ECG. Notamment en r\u00e9alisant des \u00e9tudes cliniques \u00e0 grande \u00e9chelle. Bellabeat se distingue par le fait que ses trackers, ses capteurs et ses algorithmes sont sp\u00e9cifiquement con\u00e7us pour les utilisatrices. Cela permet de r\u00e9aliser des essais et des ensembles de donn\u00e9es moins influenc\u00e9s par les pr\u00e9jug\u00e9s sexistes.<\/p>\n\n\n\n

Ur\u0161ka Sr\u0161en, cofondateur de Bellabeat, est conscient de la difficult\u00e9 dans laquelle il s\u2019engage. \u00ab Nous savons que le processus d'approbation et de certification des dispositifs m\u00e9dicaux aux \u00c9tats-Unis peut prendre jusqu'\u00e0 cinq ans. Nous veillons donc \u00e0 ce qu'il n'y ait aucun retard pr\u00e9visible dans nos essais. Nous sommes ravis d'\u00eatre un acteur fort qui prend la t\u00eate du suivi et du traitement de tout ce qui concerne la sant\u00e9 des femmes.<\/em> \u00bb<\/p>\n\n\n\n

Une clinique priv\u00e9e de Floride utilise d\u00e9sormais les bracelets Leaf comme outil pour traiter la d\u00e9pression et l'anxi\u00e9t\u00e9 chez les femmes. Les m\u00e9decins utilisent les donn\u00e9es avant et apr\u00e8s l'utilisation des m\u00e9dicaments et peuvent adapter le traitement si n\u00e9cessaire. Ils surveillent \u00e9galement les effets des techniques de respiration et de la m\u00e9ditation dans le cadre du processus de traitement. La soci\u00e9t\u00e9 femtech a annonc\u00e9 qu'une cinquantaine d'autres cliniques suivront cette ann\u00e9e.<\/p>\n\n\n\n

Ivy et les autres Bijoux Femtech<\/h3>\n\n\n\n

Bellabeat a \u00e9t\u00e9 fond\u00e9e en 2013<\/a> et est bas\u00e9e \u00e0 San Francisco. La soci\u00e9t\u00e9 a lev\u00e9 plus de 18 millions de dollars de capitaux aupr\u00e8s d'investisseurs au cours des derni\u00e8res ann\u00e9es. Depuis le d\u00e9but de 2021, elle a mis \u00e0 disposition 10 millions de dollars par le biais d'un fonds. Il s'adresse aux chercheurs et aux entreprises qui con\u00e7oivent des solutions innovantes dans le domaine de la d\u00e9pression post-natale.<\/p>\n\n\n\n

Outre Ivy, la soci\u00e9t\u00e9 femtech propose \u00e9galement les bracelets Leaf. Ce sont les premiers bijoux intelligents d\u00e9velopp\u00e9s par Bellabeat. Ivy est cependant consid\u00e9r\u00e9e comme la version la plus compl\u00e8te avec des capteurs am\u00e9lior\u00e9s et davantage de possibilit\u00e9s de suivi. Elle est \u00e9galement 30 % plus l\u00e9g\u00e8re que Leaf. Les bijoux intelligents ne sont pas bon march\u00e9. Ivy co\u00fbte 250 dollars. D'autres gadgets de Bellabeat, destin\u00e9s notamment aux femmes, sont la gourde intelligente Spring et la smartwatch Time. L'entreprise femtech tente \u00e9galement d'atteindre les femmes par le biais de son programme de bien-\u00eatre en entreprise. Par exemple, les employ\u00e9es de Coca-Cola utilisent d\u00e9sormais Bellabeat.<\/p>\n","protected":false},"excerpt":{"rendered":"

Ivy est un tracker de sant\u00e9 et ressemble \u00e0 un bijou. Il est con\u00e7u sp\u00e9cialement pour les femmes et permet de suivre leur cycle menstruel, […]<\/p>\n","protected":false},"author":42,"featured_media":54807,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4649,4651,4675,4661],"tags":[5507,4836,4709,4826,5730,5731,5732,4878,4880],"class_list":["post-54842","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-femtech-fr","category-fitness-wellness-fr","category-portables","category-telesante","tag-digital-therapeutics-2","tag-e-sante","tag-femtech-fr","tag-innovation","tag-ivy","tag-menstruation","tag-pregnacy","tag-soins-a-distance","tag-soins-numeriques"],"acf":[],"yoast_head":"\nBellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy - Smarthealth<\/title>\n<meta name=\"description\" content=\"Ivy est un tracker de sant\u00e9 qui ressemble \u00e0 un bijou. Il est con\u00e7u sp\u00e9cialement pour les femmes et permet de suivre leur cycle menstruel, entre autres.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy\" \/>\n<meta property=\"og:description\" content=\"Ivy est un tracker de sant\u00e9 qui ressemble \u00e0 un bijou. Il est con\u00e7u sp\u00e9cialement pour les femmes et permet de suivre leur cycle menstruel, entre autres.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/\" \/>\n<meta property=\"og:site_name\" content=\"Smarthealth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/smarthealthnl\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-22T06:32:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-22T08:47:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smarthealth.live\/wp-content\/uploads\/2022\/02\/Bellabeat.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sebas Eikholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SmartHealthNL\" \/>\n<meta name=\"twitter:site\" content=\"@SmartHealthNL\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sebas Eikholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/\"},\"author\":{\"name\":\"Sebas Eikholt\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/person\\\/0e4910a90a4d77ab7745f11e961ebf6b\"},\"headline\":\"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy\",\"datePublished\":\"2022-02-22T06:32:25+00:00\",\"dateModified\":\"2022-02-22T08:47:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/\"},\"wordCount\":785,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Bellabeat.jpg\",\"keywords\":[\"digital therapeutics\",\"e-sant\u00e9\",\"femtech\",\"innovation\",\"Ivy\",\"menstruation\",\"pregnacy\",\"soins \u00e0 distance\",\"soins num\u00e9riques\"],\"articleSection\":[\"femtech\",\"fitness & wellness\",\"portables\",\"t\u00e9l\u00e9sant\u00e9\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/\",\"name\":\"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy - Smarthealth\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Bellabeat.jpg\",\"datePublished\":\"2022-02-22T06:32:25+00:00\",\"dateModified\":\"2022-02-22T08:47:40+00:00\",\"description\":\"Ivy est un tracker de sant\u00e9 qui ressemble \u00e0 un bijou. Il est con\u00e7u sp\u00e9cialement pour les femmes et permet de suivre leur cycle menstruel, entre autres.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Bellabeat.jpg\",\"contentUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Bellabeat.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"Bellabeat Ivy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2022\\\/02\\\/22\\\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/\",\"name\":\"Smarthealth\",\"description\":\"Het kennisplatform voor digital health\",\"publisher\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#organization\",\"name\":\"SmartHealth\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logofutura400PIXBREED.png\",\"contentUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logofutura400PIXBREED.png\",\"width\":400,\"height\":96,\"caption\":\"SmartHealth\"},\"image\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/smarthealthnl\\\/\",\"https:\\\/\\\/x.com\\\/SmartHealthNL\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/person\\\/0e4910a90a4d77ab7745f11e961ebf6b\",\"name\":\"Sebas Eikholt\",\"description\":\"Sebas werkt als redacteur bij SmartHealth. Hij heeft in 2012 de master Media Studies afgerond aan de Erasmus Universiteit Rotterdam. Hij is daarna o.a. werkzaam geweest bij Apple in Madrid, als freelance journalist en als redacteur bij het gezondheidsplatform Patient Empowerment.\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/author\\\/sebas-eikholt\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy - Smarthealth","description":"Ivy est un tracker de sant\u00e9 qui ressemble \u00e0 un bijou. Il est con\u00e7u sp\u00e9cialement pour les femmes et permet de suivre leur cycle menstruel, entre autres.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/","og_locale":"fr_FR","og_type":"article","og_title":"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy","og_description":"Ivy est un tracker de sant\u00e9 qui ressemble \u00e0 un bijou. Il est con\u00e7u sp\u00e9cialement pour les femmes et permet de suivre leur cycle menstruel, entre autres.","og_url":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/","og_site_name":"Smarthealth","article_publisher":"https:\/\/www.facebook.com\/smarthealthnl\/","article_published_time":"2022-02-22T06:32:25+00:00","article_modified_time":"2022-02-22T08:47:40+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/smarthealth.live\/wp-content\/uploads\/2022\/02\/Bellabeat.jpg","type":"image\/jpeg"}],"author":"Sebas Eikholt","twitter_card":"summary_large_image","twitter_creator":"@SmartHealthNL","twitter_site":"@SmartHealthNL","twitter_misc":{"\u00c9crit par":"Sebas Eikholt","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/#article","isPartOf":{"@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/"},"author":{"name":"Sebas Eikholt","@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/person\/0e4910a90a4d77ab7745f11e961ebf6b"},"headline":"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy","datePublished":"2022-02-22T06:32:25+00:00","dateModified":"2022-02-22T08:47:40+00:00","mainEntityOfPage":{"@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/"},"wordCount":785,"commentCount":0,"publisher":{"@id":"https:\/\/smarthealth.live\/fr\/#organization"},"image":{"@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/#primaryimage"},"thumbnailUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2022\/02\/Bellabeat.jpg","keywords":["digital therapeutics","e-sant\u00e9","femtech","innovation","Ivy","menstruation","pregnacy","soins \u00e0 distance","soins num\u00e9riques"],"articleSection":["femtech","fitness & wellness","portables","t\u00e9l\u00e9sant\u00e9"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/","url":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/","name":"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy - Smarthealth","isPartOf":{"@id":"https:\/\/smarthealth.live\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/#primaryimage"},"image":{"@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/#primaryimage"},"thumbnailUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2022\/02\/Bellabeat.jpg","datePublished":"2022-02-22T06:32:25+00:00","dateModified":"2022-02-22T08:47:40+00:00","description":"Ivy est un tracker de sant\u00e9 qui ressemble \u00e0 un bijou. Il est con\u00e7u sp\u00e9cialement pour les femmes et permet de suivre leur cycle menstruel, entre autres.","breadcrumb":{"@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/#primaryimage","url":"https:\/\/smarthealth.live\/wp-content\/uploads\/2022\/02\/Bellabeat.jpg","contentUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2022\/02\/Bellabeat.jpg","width":1920,"height":1080,"caption":"Bellabeat Ivy"},{"@type":"BreadcrumbList","@id":"https:\/\/smarthealth.live\/fr\/2022\/02\/22\/bellabeat-entame-la-procedure-de-la-fda-pour-son-bijou-feminin-ivy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smarthealth.live\/fr\/"},{"@type":"ListItem","position":2,"name":"Bellabeat entame la proc\u00e9dure de la FDA pour son bijou f\u00e9minin Ivy"}]},{"@type":"WebSite","@id":"https:\/\/smarthealth.live\/fr\/#website","url":"https:\/\/smarthealth.live\/fr\/","name":"Smarthealth","description":"Het kennisplatform voor digital health","publisher":{"@id":"https:\/\/smarthealth.live\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smarthealth.live\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/smarthealth.live\/fr\/#organization","name":"SmartHealth","url":"https:\/\/smarthealth.live\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/smarthealth.live\/wp-content\/uploads\/2013\/07\/logofutura400PIXBREED.png","contentUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2013\/07\/logofutura400PIXBREED.png","width":400,"height":96,"caption":"SmartHealth"},"image":{"@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/smarthealthnl\/","https:\/\/x.com\/SmartHealthNL"]},{"@type":"Person","@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/person\/0e4910a90a4d77ab7745f11e961ebf6b","name":"Sebas Eikholt","description":"Sebas werkt als redacteur bij SmartHealth. Hij heeft in 2012 de master Media Studies afgerond aan de Erasmus Universiteit Rotterdam. Hij is daarna o.a. werkzaam geweest bij Apple in Madrid, als freelance journalist en als redacteur bij het gezondheidsplatform Patient Empowerment.","url":"https:\/\/smarthealth.live\/fr\/author\/sebas-eikholt\/"}]}},"_links":{"self":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts\/54842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/comments?post=54842"}],"version-history":[{"count":3,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts\/54842\/revisions"}],"predecessor-version":[{"id":54848,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts\/54842\/revisions\/54848"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/media\/54807"}],"wp:attachment":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/media?parent=54842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/categories?post=54842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/tags?post=54842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}